Zemdri
1 known investors
ZEMDRI (plazomicin) is an aminoglycoside antibiotic injection indicated for adults with complicated urinary tract infections, including pyelonephritis, caused by certain susceptible microorganisms. The product is a prescription pharmaceutical marketed by Cipla Therapeutics.
Investors · 1
Frequently asked questions
- What does Zemdri do?
- ZEMDRI (plazomicin) is an aminoglycoside antibiotic injection indicated for adults with complicated urinary tract infections, including pyelonephritis, caused by certain susceptible microorganisms. The product is a prescription pharmaceutical marketed by Cipla Therapeutics.
- Who are Zemdri's investors?
- Zemdri's investors include Frazier Life Sciences.